Hepatic Copper Accumulation Predicts Fibrosis Progression and Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Sex, ethnicity, metabolic comorbidities, and baseline fibrosis stage did not reach statistical significance in the fully adjusted model, suggesting that hepatic copper and smoking were the primary independent determinants of mortality in this cohort.

also in 111,027 other papers